Open Science Institute™ is partnering with CytoSolve® to advance model development in different biological areas as shown below
Research Pipeline
Dr. Shiva Ayyadurai, MIT PhD, the Man Who Invented Email, is now Revolutionizing Health with his creation of CytoSolve®, a pioneering technology platform for computational systems biology that goes beyond AI to deliver a scientifically validated, scalable, and repeatable framework that provides a systems-level understanding of disease and complex biological systems, in silico, thereby reducing and even eliminating the need for animal testing, to discover multi-combination therapies that address the root cause of biological dysfunction.
CytoSolve’s Six-Phased Systems Biology Research Paradigm delivers discovery, development, and validation that are faster, cheaper, and safer than existing traditional reductionist approaches. Using this paradigm, CytoSolve® has engineered multi-ingredient drug and nutraceutical combinations in silico that have been cleared by the U.S. Food and Drug Administration (FDA) to advance to human clinical trials—without the need for animal testing.
